Latest Revenue Growth News

Vitrafy Life Sciences reports strong progress in cryopreservation technology development and US market expansion following a successful $35 million IPO. The company highlights improved biological sample preservation outcomes and strategic commercial milestones.

News Corporation reported a robust second quarter for Fiscal 2025, with revenues climbing 5% to $2.24 billion and net income soaring 58%, while announcing the strategic sale of Foxtel to DAZN for A$3.4 billion.

REA Group has reported a robust half-year performance for H1 FY25, with revenue climbing 20% to $873 million and net profit surging 26%, driven by strong Australian and Indian market momentum and strategic technology investments.

REA Group has delivered a robust first half FY25 performance, posting a 20% revenue increase and a 26% rise in net profit, underpinned by strong Australian and Indian market growth. The company also announced a 26% higher interim dividend, signaling confidence in its ongoing momentum.

REA Group Ltd has delivered a robust half-year performance, reporting a 20% increase in revenue to $872.9 million and a 26% rise in net profit after tax to $313.9 million, driven by strong growth in both Australian and Indian markets.

DigitalX Limited has completed the placement of all shortfall shares from its recent rights issue, raising a total of approximately $5.09 million and attracting new supportive shareholders. The company is deploying these funds to expand revenue-generating staking activities within the digital asset space.

InFocus Group Holdings has completed its acquisition of Bangkok-based Prodigy9, enhancing its software engineering and data analytics capabilities while aiming for rapid cash flow generation.

Audeara Limited has landed a significant US$917,000 follow-up purchase order from a global music instrument manufacturer, reinforcing the commercial viability of its hearing technology and expanding its licensing footprint.

Evion Group has successfully raised $1.33 million through a rights issue, positioning itself to accelerate production at its Panthera JV in India. The company also announced a bonus options offer to reward shareholders and support future expansion.

Tower Limited has raised its full-year underlying NPAT guidance to $60m-$70m, citing strong first-quarter results and favourable claims trends despite softer premium growth.

Xref Limited reported a solid 10% revenue increase to $10.9 million in H1 FY2025, even as a proposed acquisition by SEEK was narrowly rejected by shareholders. The company plans to continue its growth trajectory as an independent ASX-listed entity with new product launches on the horizon.

Wellnex Life has secured Therapeutic Goods Administration approval for its Liquid Paracetamol plus Caffeine Soft Gel, marking its fourth market authorisation and opening new revenue avenues.